Introduction
============

Infectious endophthalmitis is a sight-threatening disease. The etiology may be of exogenous or endogenous causes. It may occur after ocular trauma, intraocular surgery, or spread from adjacent structures or a distant site of infection.[@b1-opth-12-765]--[@b6-opth-12-765] Management of infectious endophthalmitis depends on accurate diagnosis and prompt antimicrobial treatment. Causative microorganisms may be bacteria, fungi, or mixed organisms.[@b4-opth-12-765]--[@b7-opth-12-765] Microbiological laboratory investigation of the intraocular fluid specimens is, therefore, crucial to the identification of these causative microorganisms.[@b8-opth-12-765]--[@b10-opth-12-765] Treatment of infectious endophthalmitis includes specific antimicrobial drugs by various routes such as topical, subconjunctival, and intravitreal injection.[@b11-opth-12-765],[@b12-opth-12-765] In the case of medication failure, pars plana vitrectomy with intravitreal antimicrobial injection is a surgical procedure of choice.[@b13-opth-12-765]--[@b15-opth-12-765] Usually, endophthalmitis has poor visual outcome and a high rate of visual loss. Advances in vitreoretinal surgery and other additional surgical tools such as silicone oil can, however, improve the final anatomical and functional outcomes.[@b16-opth-12-765]--[@b18-opth-12-765] To the best of current knowledge, there has been no study on factors affecting visual prognosis after treatment of the whole spectrum of infectious endophthalmitis. There were only two studies on prognostic factors, one in endogenous endophthalmitis and another in acute postoperative endophthalmitis, and they involved a small sample size.[@b19-opth-12-765],[@b20-opth-12-765] The aim of this study was, therefore, to evaluate the visual outcome of patients with infectious endophthalmitis in a large consecutive series of patients and to determine the factors affecting visual outcomes in these patients.

Patients and methods
====================

This study follows the tenets of the Declaration of Helsinki, and was approved by the Khon Kaen University Ethics Committee for Human Research (HE 581036). Retrospective medical chart reviews of all patients diagnosed as clinically infectious endophthalmitis at the KKU Eye Center, Department of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand from 2012 to 2016 were performed. Patient consent to review their medical records was not required by the ethics committee, since the case report forms had no linkage to the patient identities and the researchers respected the privacy of the patients. Inclusion criteria were those who had a clinical diagnosis of infectious endophthalmitis, history of prior intraocular injury or surgery no longer than 6 weeks before, had medical or surgical treatment at the hospital, and a follow-up period of at least 6 weeks. The patients who had a history of corneal disorders or retinal diseases, which might interfere with visual acuity, were excluded from the study. Those who had active glaucoma and uncontrolled diabetes mellitus were also excluded. The collected data including age, gender, occupation, underlying diseases, history of ocular injury and intraocular surgery, initial and final best-corrected visual acuity (BCVA) examinations, the treatment procedures, and anatomical and functional outcomes. Causative organisms identified were also recorded.

Microbiological investigations of vitreous fluids were done in all patients. Undiluted vitreous specimens were obtained by vitreous aspiration through a 23-gauge needle. The vitreous specimens were inoculated on blood agar, chocolate agar, MacConkey agar, and Sabouraud dextrose agar, as well as in thioglycolate broth and blood culture bottles. The causative organisms were then identified and reported. In the case of endogenous endophthalmitis, hemocultures or cultures from extraocular infection sites were also performed.

The medical treatments consisted of intravitreal vancomycin (1 mg/0.1 mL) and ceftazidime (2.25 mg/0.1 mL). Intensive topical and systemic antibiotics were also included. Surgical treatment consisted of pars plana vitrectomy and intravitreal antibiotics. This was indicated in patients with the loss of red reflex and substantial vitreous opacity on ultrasonography. In severe cases, pars plana vitrectomy combined with silicone oil tamponade was performed, depending on the decisions of the surgeons.

The primary outcomes were factors affecting the visual outcomes after treatment. The patients were classified as "improved" visual outcome when their final BCVA was one or more Snellen acuity line better than initial BCVA. They were classified as "worse" when final BCVA was one or more Snellen acuity line worse than initial BCVA. Stable visual outcome was defined when final BCVA did not change from initial BCVA. The secondary outcomes were types of infectious endophthalmitis, types of causative organisms, and types of treatment modalities.

Statistical analysis was performed using STATA version 10.0 (StataCorp LP, College Station, TX, USA). The categorical data, such as gender, affected eyes, underlying diseases, types of endophthalmitis, treatment procedures, and visual outcomes, are shown in numbers and percentages. The numerical data, such as numbers of positive cultures and causative organisms, are also reported in numbers and percentages. Age is shown as mean±standard deviation and range. Visual outcomes after treatment in different patient groups were compared and analyzed using chi-square test and odds ratios with 95% confidence intervals. The differences were considered significant when the *P*-value was \<0.05.

Results
=======

A total of 411 patients and 417 eyes with clinically infectious endophthalmitis were recruited into the study. There were 287 male and 124 female patients. The mean age was 50.99±20.76 years and ranged from 18--89 years. Two hundred and eighteen (53.04%) right eyes and 187 (45.50%) left eyes were affected. There were six cases (1.46%) having both eyes affected. The types of endophthalmitis in this study are shown in [Table 1](#t1-opth-12-765){ref-type="table"}. One hundred and eighty-three patients had a history of ocular trauma before the infection. One hundred and thirty-two patients developed infection after intraocular surgery. Seventy-two patients were diagnosed with endogenous endophthalmitis by evidence of extraocular infection sites.

Positive cultures were found in 172 (41.25%) of 417 eyes. Bacteria were isolated in 157 eyes (91.28%), fungi in eight eyes (4.65%), and mixed organisms in seven eyes (4.07%). The data on specific causative microorganisms are summarized in [Table 2](#t2-opth-12-765){ref-type="table"}. There were Gram positives in 120 eyes (76.43%) and Gram negatives in 37 eyes (23.57%). The most frequent bacteria were coagulase-negative *Staphylococcus* (36), *Bacillus* spp. (24), *Streptococcus pneumonia* (20), β-hemolytic streptococcus (12), *Pseudomonas* spp. (9), *Klebsiella* spp. (9), and *Enterococcus* spp. (8), in descending order of frequency. It is interesting that the most common organism in post-traumatic endophthalmitis was *Bacillus* spp., whereas coagulase-negative *Staphylococcus* was the most frequent organism in post-operative type. Group B β hemolytic Streptococcus, *Klebsiella* spp., and *Escherichia coli* were the three most common organisms identified in patients with endogenous endophthalmitis. It is also noted from [Table 2](#t2-opth-12-765){ref-type="table"} that *Pseudomonas aeruginosa* was commonly identified in endophthalmitis associated with keratitis, and *Streptococcus* spp. was common in bleb-related infection. In addition, almost all patients with mixed organisms developed endophthalmitis after ocular trauma.

Treatment modalities, including medical treatment, pars plans vitrectomy with or without silicone oil tamponade, and destructive surgery (evisceration or enucleation) are shown in [Table 3](#t3-opth-12-765){ref-type="table"}. The most common method of treatment was pars plana vitrectomy (261 eyes, 62.29%). Infection was controlled by medical treatment in 78 eyes (18.71%), and there were 78 eyes (18.71%) ending up with evisceration or enucleation.

The initial visual acuities and final visual outcomes are compared in [Figure 1](#f1-opth-12-765){ref-type="fig"}. The majority of patients (332/417, 79.62%) had initial visual acuity of hand motion (191), light perception (93), or no light perception (48). Final visual outcomes that are reported as improved, stable, and worse are shown in [Figures 2](#f2-opth-12-765){ref-type="fig"}[](#f3-opth-12-765){ref-type="fig"}--[4](#f4-opth-12-765){ref-type="fig"}. In addition to 78 eyes (18.71%) with eye removal, the visual acuities were improved in 186 eyes (44.6%), stable in 77 eyes (18.47%), and worse in 76 eyes (18.22%). It is noted that treatment could improve visual outcome and at least stabilize the vision in 263 eyes (63.07%). The improved visual outcomes according to the type of endophthalmitis, treatment modalities, and initial visual acuity before treatment are also shown in [Figures 2](#f2-opth-12-765){ref-type="fig"}[](#f3-opth-12-765){ref-type="fig"}--[4](#f4-opth-12-765){ref-type="fig"}.

Factors affecting the visual outcomes are demonstrated in [Table 4](#t4-opth-12-765){ref-type="table"}. It revealed that the types of endophthalmitis, types of causative organisms, and initial visual acuity are factors associated with improved visual outcome with statistically significant differences. Post-operative endophthalmitis had the most favorable visual outcome when compared to endogenous and bleb-related types (*P*\<0.001). Coagulase-negative *Staphylococcus* had the most favorable visual outcome when compared to Bacillus, Streptococcus, and mixed infections (*P*=0.003). The initial vision capable of counting fingers had the most favorable visual outcome when compared to initial visual acuity of light perception (*P*=0.017).

Discussion
==========

The most common type of infectious endophthalmitis in this study was post-traumatic endophthalmitis. This was not consistent with the reviewed literatures that reported postoperative cause as the most common type.[@b4-opth-12-765],[@b6-opth-12-765],[@b21-opth-12-765] This study, however, agrees with previous studies in Thailand.[@b5-opth-12-765],[@b8-opth-12-765],[@b9-opth-12-765] This may be attributed to a higher incidence of ocular trauma, especially with vegetative material, in the rural areas. Post-operative endophthalmitis was the next most common and similar to other previous studies, where most of the patients developed infection after cataract surgery.[@b4-opth-12-765],[@b5-opth-12-765],[@b21-opth-12-765]

In all types of endophthalmitis, accurate diagnosis should be accomplished by clinical and microbiological laboratory investigation. Smears and cultures of intraocular fluid specimens for identification of the causative organisms are still used as a gold standard for diagnosis. In the present study, both conventional culture media and blood culture bottles were used for culture of the vitreous fluid specimens, because this laboratory's previous studies revealed that vitreous culture in blood culture bottles yielded more positive results than conventional culture media, and a combination of both improved the possibility of a positive culture.[@b8-opth-12-765],[@b9-opth-12-765] The culture yield in this study was only 41.25%. This may be attributed to many factors. The possibility may be that the patients had been partially treated with antimicrobial therapy before referral to the KKU Eye Center. Another reason may be that some causative organisms need specific media or conditions for growth that were not provided in the study.

In this study, the most common type of organisms were Gram-positive bacteria, and the majority of them was coagulase-negative *Staphylococcus*. This result agrees well with other previous studies.[@b4-opth-12-765],[@b5-opth-12-765],[@b8-opth-12-765],[@b20-opth-12-765],[@b21-opth-12-765] The next most common Gram-positive bacteria were *Bacillus* spp. and *Streptococcus pneumoniae*. This finding is also similar to other previous studies.[@b5-opth-12-765],[@b8-opth-12-765],[@b9-opth-12-765] The three most common Gram-negative bacteria were *Pseudomonas aeruginosa*, *Klebsiella* spp., and *Enterobacter* spp. This is also in agreement with previous reports.[@b5-opth-12-765],[@b8-opth-12-765],[@b9-opth-12-765] There were eight eyes with fungal endophthalmitis. Six of them were *Aspergillus* spp. This is in contrast to a previous study that reported *Candida* spp. as the most frequent fungus isolates.[@b21-opth-12-765] In addition, there were seven eyes with endophthalmitis caused by mixed organisms. Most of them developed endophthalmitis after ocular trauma.

Factors associated with an improved visual outcome were analyzed. When compared to other types of endophthalmitis, the post-operative type had the most favorable visual outcome ([Figure 2](#f2-opth-12-765){ref-type="fig"} and [Table 4](#t4-opth-12-765){ref-type="table"}). This may be attributed to the awareness of both patients and ophthalmologists, so that most patients had early diagnosis and treatment. Fortunately, the causative organisms were mostly coagulase-negative *Staphylococcus*, which is less virulent ([Table 2](#t2-opth-12-765){ref-type="table"}). Post-traumatic endophthalmitis usually has virulent Bacillus and mixed infections that result in a poor visual prognosis.[@b22-opth-12-765]--[@b24-opth-12-765] The visual outcome of endogenous endophthalmitis is rather poor, due to the virulence of the organisms and compromised host conditions.[@b19-opth-12-765]

Regarding causative organisms, patients with coagulase-negative *Staphylococcus* endophthalmitis had more improved visual outcomes than other organisms with a statistically significant difference. This finding is similar to a previous report.[@b20-opth-12-765] When compared to other Gram-positive bacterial infections, patients with Bacillus and Streptococcus endophthalmitis seemed to have a poor visual prognosis. Mixed infections with Bacillus, Gram-negative bacteria, or fungi in post-traumatic patients were associated with the most unfavorable visual outcomes. This is also consistent with other previous studies.[@b22-opth-12-765]--[@b24-opth-12-765] In this study, mixed organisms, either mixed bacterial or mixed bacterial and fungal infections, had the poorest visual prognosis. Only one of seven eyes had vision improvement, three eyes had a worse visual outcome, and three eyes had evisceration or enucleation.

In this study, pars plana vitrectomy had a slightly more improved visual outcome than other treatment modalities, but the difference was not statistically significant ([Figure 3](#f3-opth-12-765){ref-type="fig"} and [Table 4](#t4-opth-12-765){ref-type="table"}). Although vitrectomy seems to be the best treatment modality, because it removes the bulk of organism loads and facilitates the distribution of intravitreal antibiotics,[@b13-opth-12-765]--[@b15-opth-12-765] vitrectomy cannot be compared with other methods of treatment in this study, since patients in each treatment group had different degrees of severity. Patients in the medical treatment group usually had a mild degree of infection, whereas those in the surgical treatment group had more severe clinical signs of infection. This may be one of the reasons why there is no significant difference in the association.

Initial visual acuity before treatment was also associated with improved visual outcome. Initial vision of hand motion or better had a more favorable visual outcome than the initial visual acuity of only light perception, with a statistically significant difference ([Figure 4](#f4-opth-12-765){ref-type="fig"} and [Table 4](#t4-opth-12-765){ref-type="table"}). Patients with only light perception before treatment had the worst visual prognosis. They only had a one-third chance of improved visual outcome (34 eyes), whereas 11 eyes had stable vision, and most of them (48 eyes) had worse vision (34 of 48 eyes were eviscerated or enucleated). It is also noted that there were four patients with 6/9 vision before treatment. Although between them they had only one eye (25%) with improved visual outcome, all of the remaining three eyes had stable vision. This indicates that all of them preserved their initial vision.

Conclusion
==========

Visual outcomes after treatment of patients with infectious endophthalmitis have been studied. Most patients in this study had post-traumatic endophthalmitis. The most common causative organisms were Gram-positive bacteria, particularly coagulase-negative *Staphylococcus*. Factors associated with improved visual outcome have been analyzed. Post-operative type of endophthalmitis, coagulase-negative *Staphylococcus*, and initial visual acuity of hand motion or better were regarded as important factors associated with improved visual outcome. Although infectious endophthalmitis is a devastating eye disease, and treatment could not change the virulence of causative organisms and its poor visual outcome, this study demonstrated that microbiological laboratory investigation of vitreous specimens and prompt specific antimicrobial therapy and/or surgical treatment could improve or at least stabilize some useful vision, even in patients with poor initial visual acuity.

The strength of this study was a large series of patients. An obvious limitation was that it was a retrospective study. There might be some important data not recorded in the medical charts. In this study, data on time to presentation and the presence of relative afferent pupillary defects are missing. Another limitation was that the number of patients in each subgroup might be too small for statistically significant differences and conclusion. It is recommended that further prospective studies with larger sample sizes should be pursued.
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![Initial best-corrected visual acuity before and after treatment.\
**Abbreviations:** NLP, no light perception; LP, light perception; HM, hand motion; CF1, counting finger at 1 foot; CF2, counting finger at 2 feet; CF3, counting finger at 3 feet.](opth-12-765Fig1){#f1-opth-12-765}

![Visual outcomes vs different types of endophthalmitis.\
**Abbreviation:** IVT, intravitreal injection.](opth-12-765Fig2){#f2-opth-12-765}

![Visual outcomes vs different treatment modalities.\
**Abbreviations:** PPV, pars plana vitrectomy; PPV+SO, pars plana vitrectomy and silicone oil tamponade.](opth-12-765Fig3){#f3-opth-12-765}

![Visual outcomes vs initial visual acuity before treatment.\
**Abbreviations:** LP, light perception; HM, hand motion; CF1, counting finger at 1 foot; CF3, counting finger at 3 feet.](opth-12-765Fig4){#f4-opth-12-765}

###### 

Types of endophthalmitis in 411 patients in the study

  Types of endophthalmitis      No    Percentage
  ----------------------------- ----- ------------
  Post-traumatic                183   44.53
  Post-operative                132   32.12
  Endogenous                    72    17.52
  Keratitis-associated          16    3.89
  Bleb-related                  5     1.22
  Post-intravitreal injection   3     0.72
  Total                         411   100.00

###### 

Number of causative organisms found in positive cultures of 172 eyes

  Organisms                                                Post-trauma   Post-operative   Endogenous   Keratitis associated   Bleb-related   Post-injection   Total
  -------------------------------------------------------- ------------- ---------------- ------------ ---------------------- -------------- ---------------- -------
  **Bacteria**                                                                                                                                                157
  Gram-positive                                                                                                                                               120
   Coagulase-negative Staphylococcus                       9             21               4            --                     --             2                36
   *Bacillus* spp.                                         23            1                --           --                     --             --               24
   *Streptococcus pneumonia*                               4             11               3            2                      --             --               20
   β-Hemolytic Streptococcus                               --            1                11           --                     --             --               12
   *Enterococcus* spp.                                     4             2                1                                   1                               8
   *Streptococcus viridans*                                3             4                --           --                     --             --               7
   *Corynebacterium* spp.                                  4             1                --           1                      --             --               6
   *Streptococcus suis*                                    --            --               2            --                     --             --               2
   *Streptococcus* spp.                                    --            --               --           --                     2              --               1
   β-Nonhemolytic Strepcoccus                              --            --               1            --                     --             --               1
   *Nocardia* spp.                                         1             --               --           --                     --             --               1
   *Micrococcus* spp.                                      --            --               --           1                      --             --               1
   *Propionibacterium acne*                                --            1                --           --                     --             --               1
  Gram negative                                                                                                                                               37
   *Pseudomonas aeruginosa*                                5             --               --           4                      --             --               9
   *Klebsiella* spp.                                       --            1                8            --                     --             --               9
   *Enterobacter* spp.                                     3             1                1            --                     1              --               6
   *Escherichia coli*                                      --            1                4            --                     --             --               5
   *Stenotrophomonas* spp.                                 --            --               1            --                     --             --               1
   *Haemophilus parainfluenzae*                            --            1                --           --                     --             --               1
   *Serratia* spp.                                         --            --               --           --                     1              --               1
   *Burkholderia* spp.                                     --            1                --           --                     --             --               1
   *Bordetella* spp.                                       1             --               --           --                     --             --               1
   *Acinetobacter baumannii*                               --            1                --           --                     --             --               1
   *Aeromonas hydrophila*                                  1             --               --           --                     --             --               1
  Fungus                                                                                                                                                      8
   *Aspergillus* spp.                                      1             3                1            1                      --             --               6
   *Fusarium* spp.                                         1             --               --           1                      --             --               2
  Mixed organisms                                                                                                                                             7
   *Bacillus* spp. + coagulase-negative *Staphylococcus*   1             1                --           --                     --             --               2
   *Bacillus* spp. + *Enterobacter* spp. + *E. coli*       1             --               --           --                     --             --               1
   *Bacillus* spp. + *Curvularia* spp.                     1             --               --           --                     --             --               1
   *S. viridans* + *Enterobacter* spp. + *E. coli*         1             --               --           --                     --             --               1
   *S. viridans* + *Aspergillus* spp.                      1             --               --           --                     --             --               1
   *Aspergillus* spp. + *Penicillium* spp.                 1             --               --           --                     --             --               1

###### 

Treatment modalities of 417 eyes in the study

  Treatment modalities                     No    Percentage
  ---------------------------------------- ----- ------------
  Medical treatment                        78    18.71
  Pars plana vitrectomy                    174   41.72
  Par plana vitrectomy with silicone oil   87    20.86
  Destructive surgery                      78    18.71
  Total                                    417   100.00

###### 

Factors associated with improved visual outcome

  Factors                              Improved visual outcome, n (%)   Odds ratio (95% CI)    *P*-value
  ------------------------------------ -------------------------------- ---------------------- -----------
  **Types of endophthalmitis**                                                                 \<0.001
  Post-operative                       78/132 (59.09)                   5.60 (0.61--51.48)     
  Post-traumatic                       84/183 (45.90)                   3.39 (0.37--30.95)     
  Post-intravitreal injection          1/3 (33.33)                      2.00 (0.08--51.59)     
  Post-keratitis                       5/16 (31.25)                     1.82 (0.16--20.71)     
  Endogenous                           17/72 (23.61)                    1.24 (0.13--11.82)     
  Bleb-related                         1/5 (20)                         1.00                   
  **Types of organisms**                                                                       0.003
  Gram positive                                                                                
   Coagulase-negative Staphylococcus   24/36 (66.67)                    12.00 (1.29--111.32)   
   *Bacillus* spp.                     5/24 (20.83)                     1.58 (0.15--16.31)     
   *Streptococcus pneumoniae*          3/20 (15.00)                     1.06 (0.09--12.23)     
   Other Gram positive                 16/40 (40.00)                    4.00 (0.44--36.44)     
  Gram negative                                                                                
   *Pseudomonas* spp.                  3/9 (33.33)                      3.00 (0.24--37.67)     
   *Klebsiella* spp.                   2/9 (22.22)                      1.71 (0.12--23.94)     
   *Escherichia coli*                  1/5 (20.00)                      1.50 (0.07--31.57)     
   Other Gram negative                 4/14 (28.57)                     2.40 (0.21--26.82)     
  Fungus                               2/8 (25)                         2.00 (0.14--28.42)     
  Mixed organisms                      1/7 (14.29)                      1.00                   
  **Treatment modalities**                                                                     0.26
  Medical treatment                    41/78 (52.56)                    1.16 (0.62--2.17)      
  PPV                                  102/174 (58.62)                  1.53 (0.90--2.61)      
  PPV with silicone oil                43/87 (49.43)                    1.00                   
  **Initial visual acuity**                                                                    0.017
  6/6--6/9                             1/4 (25)                         0.58 (0.06--5.78)      
  6/12--6/24                           6/14 (42.86)                     1.30 (0.42--4.07)      
  6/36--6/60                           12/21 (57.14)                    2.31 (0.88--6.05)      
  5/60--1/60                           4/8 (50)                         1.73 (0.41--7.39)      
  Counting fingers                     26/38 (68.42)                    3.74 (1.68--8.40)      
  Hand motion                          103/191 (53.93)                  2.03 (1.22--3.38)      
  Light perception                     34/93 (36.56)                    1.00                   

**Abbreviations:** n, number; CI, confidence interval; PPV, pars plana vitrectomy.
